Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy-Reference-Cited by-同舟云学术

Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy

Published:2016-03 Issue: Volume:207 Page:168-176
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Tarantini Giuseppe,Nai Fovino Luca,Tellaroli Paola,Chieffo Alaide,Barioli Alberto,Menozzi Alberto,Frasheri Arian,Garbo Roberto,Masotti-Centol Monica,Salvatella Neus,Dominguez Juan Francisco Oteo,Steffanon Luigi,Presbitero Patrizia,Pucci Edoardo,Fraccaro Chiara,Mauri Josepa,Giustino Gennaro,Sardella Gennaro,Colombo Antonio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. 2014 ESC/EACTS guidelines on myocardial revascularization;Windecker;Eur. Heart J.,2014

2. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy the SECURITY randomized clinical trial;Colombo;J. Am. Coll. Cardiol.,2014

3. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents the efficacy of Xience/Promus versus cypher to reduce late loss after stenting (EXCELLENT) randomized;Gwon;Multicent. Study Circ.,2012

4. Standardized bleeding definitions for cardiovascular clinical trials a consensus report from the bleeding academic research consortium;Mehran;Circulation,2011

5. Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter?: long-term clinical outcome of 2,429-patient multicenter registry;Tarantini;Catheter. Cardiovasc. Interv.,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis;Drugs;2024-05-29

2. A more-Comers populAtion trEated with an ultrathin struts polimer-free Sirolimus stent: an Italian post-maRketing study (the CAESAR registry);Frontiers in Cardiovascular Medicine;2024-01-08

3. Moderate Symptomatic Aortic Stenosis: A New Trigger Point for Transcatheter Aortic Valve Replacement?;The American Journal of Cardiology;2023-12

4. Looking but not seeing the cap: The case for PROGRESS‐CTO;Catheterization and Cardiovascular Interventions;2023-03-19

5. A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study;EuroIntervention;2023-02